vs
CSX Corporation（CSX）与费森尤斯医疗（FMS）财务数据对比。点击上方公司名可切换其他公司
费森尤斯医疗的季度营收约是CSX Corporation的1.6倍（$5.5B vs $3.5B），CSX Corporation净利率更高（23.2% vs 7.9%，领先15.2%），CSX Corporation同比增速更快（1.7% vs -0.3%）
CSX运输是美国一级货运铁路企业，业务覆盖美国东部区域及加拿大安大略省、魁北克省，运营铁路总里程约3.4万公里，隶属于总部位于佛罗里达州杰克逊维尔市的财富500强企业CSX Corporation，是其旗下核心子公司。
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
CSX vs FMS — 直观对比
营收规模更大
FMS
是对方的1.6倍
$3.5B
营收增速更快
CSX
高出2.0%
-0.3%
净利率更高
CSX
高出15.2%
7.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.5B | $5.5B |
| 净利润 | $807.0M | $434.2M |
| 毛利率 | — | 27.4% |
| 营业利润率 | 36.0% | 11.7% |
| 净利率 | 23.2% | 7.9% |
| 营收同比 | 1.7% | -0.3% |
| 净利润同比 | 24.9% | 240.4% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSXFMS
| Q1 26 | $3.5B | — | ||
| Q4 25 | $3.5B | $5.5B | ||
| Q3 25 | $3.6B | — | ||
| Q2 25 | $3.6B | — | ||
| Q1 25 | $3.4B | — | ||
| Q4 24 | $3.5B | $5.5B | ||
| Q3 24 | $3.6B | — | ||
| Q2 24 | $3.7B | — |
净利润CSXFMS
| Q1 26 | $807.0M | — | ||
| Q4 25 | $720.0M | $434.2M | ||
| Q3 25 | $694.0M | — | ||
| Q2 25 | $829.0M | — | ||
| Q1 25 | $646.0M | — | ||
| Q4 24 | $720.0M | $127.6M | ||
| Q3 24 | $894.0M | — | ||
| Q2 24 | $963.0M | — |
毛利率CSXFMS
| Q1 26 | — | — | ||
| Q4 25 | — | 27.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 25.0% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
营业利润率CSXFMS
| Q1 26 | 36.0% | — | ||
| Q4 25 | 31.6% | 11.7% | ||
| Q3 25 | 30.3% | — | ||
| Q2 25 | 35.9% | — | ||
| Q1 25 | 30.4% | — | ||
| Q4 24 | 30.8% | 5.1% | ||
| Q3 24 | 37.4% | — | ||
| Q2 24 | 39.1% | — |
净利率CSXFMS
| Q1 26 | 23.2% | — | ||
| Q4 25 | 20.5% | 7.9% | ||
| Q3 25 | 19.3% | — | ||
| Q2 25 | 23.2% | — | ||
| Q1 25 | 18.9% | — | ||
| Q4 24 | 20.3% | 2.3% | ||
| Q3 24 | 24.7% | — | ||
| Q2 24 | 26.0% | — |
每股收益（稀释后）CSXFMS
| Q1 26 | — | — | ||
| Q4 25 | $0.39 | — | ||
| Q3 25 | $0.37 | — | ||
| Q2 25 | $0.44 | — | ||
| Q1 25 | $0.34 | — | ||
| Q4 24 | $0.38 | — | ||
| Q3 24 | $0.46 | — | ||
| Q2 24 | $0.49 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $1.7B |
| 总债务越低越好 | $18.9B | — |
| 股东权益账面价值 | $13.6B | $15.4B |
| 总资产 | $44.2B | $33.5B |
| 负债/权益比越低杠杆越低 | 1.39× | — |
8季度趋势，按日历期对齐
现金及短期投资CSXFMS
| Q1 26 | $1.1B | — | ||
| Q4 25 | $5.0M | $1.7B | ||
| Q3 25 | $6.0M | — | ||
| Q2 25 | $6.0M | — | ||
| Q1 25 | $8.0M | — | ||
| Q4 24 | $72.0M | $1.3B | ||
| Q3 24 | $12.0M | — | ||
| Q2 24 | $4.0M | — |
总债务CSXFMS
| Q1 26 | $18.9B | — | ||
| Q4 25 | $18.2B | — | ||
| Q3 25 | $18.6B | — | ||
| Q2 25 | $18.6B | — | ||
| Q1 25 | $18.5B | — | ||
| Q4 24 | $17.9B | — | ||
| Q3 24 | $18.5B | — | ||
| Q2 24 | $18.0B | — |
股东权益CSXFMS
| Q1 26 | $13.6B | — | ||
| Q4 25 | $13.2B | $15.4B | ||
| Q3 25 | $12.8B | — | ||
| Q2 25 | $12.4B | — | ||
| Q1 25 | $12.2B | — | ||
| Q4 24 | $12.5B | $17.0B | ||
| Q3 24 | $12.9B | — | ||
| Q2 24 | $12.6B | — |
总资产CSXFMS
| Q1 26 | $44.2B | — | ||
| Q4 25 | $43.7B | $33.5B | ||
| Q3 25 | $43.3B | — | ||
| Q2 25 | $42.9B | — | ||
| Q1 25 | $43.2B | — | ||
| Q4 24 | $42.8B | $36.3B | ||
| Q3 24 | $43.1B | — | ||
| Q2 24 | $42.4B | — |
负债/权益比CSXFMS
| Q1 26 | 1.39× | — | ||
| Q4 25 | 1.38× | — | ||
| Q3 25 | 1.45× | — | ||
| Q2 25 | 1.50× | — | ||
| Q1 25 | 1.52× | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 1.43× | — | ||
| Q2 24 | 1.42× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $2.9B |
| 自由现金流经营现金流 - 资本支出 | $793.0M | — |
| 自由现金流率自由现金流/营收 | 22.8% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.58× | 6.67× |
| 过去12个月自由现金流最近4个季度 | $2.0B | — |
8季度趋势，按日历期对齐
经营现金流CSXFMS
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.4B | $2.9B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $635.0M | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.4B | $2.6B | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.1B | — |
自由现金流CSXFMS
| Q1 26 | $793.0M | — | ||
| Q4 25 | $709.0M | — | ||
| Q3 25 | $607.0M | — | ||
| Q2 25 | $-141.0M | — | ||
| Q1 25 | $536.0M | — | ||
| Q4 24 | $550.0M | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $547.0M | — |
自由现金流率CSXFMS
| Q1 26 | 22.8% | — | ||
| Q4 25 | 20.2% | — | ||
| Q3 25 | 16.9% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | 15.7% | — | ||
| Q4 24 | 15.5% | — | ||
| Q3 24 | 29.3% | — | ||
| Q2 24 | 14.8% | — |
资本支出强度CSXFMS
| Q1 26 | — | — | ||
| Q4 25 | 19.3% | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 21.7% | — | ||
| Q1 25 | 21.0% | — | ||
| Q4 24 | 23.7% | — | ||
| Q3 24 | 17.3% | — | ||
| Q2 24 | 14.6% | — |
现金转化率CSXFMS
| Q1 26 | 1.58× | — | ||
| Q4 25 | 1.93× | 6.67× | ||
| Q3 25 | 1.93× | — | ||
| Q2 25 | 0.77× | — | ||
| Q1 25 | 1.94× | — | ||
| Q4 24 | 1.93× | 20.20× | ||
| Q3 24 | 1.89× | — | ||
| Q2 24 | 1.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
